Boris Nadezhdin has undertaken notable risks in challenging Vladimir Putin for the upcoming presidential election in March. In voicing opposition to the war in...
The U.S. Food and Drug Administration (FDA) is investigating the cancer treatment CAR-T after it was notified of new blood cancers among individuals who received the treatment.